SCHEMBL3582886

SCHEMBL3582886

O=[N+]([O-])c1cc(Br)[nH]n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL162091 0.76 HPGD (0.41) —
SCHEMBL8023464 0.74 — —
SCHEMBL18529294 0.74 — —
SCHEMBL10399828 0.74 — —
SCHEMBL2427435 0.74 — —
SCHEMBL14714005 0.74 MEN1 (0.30) —
Ethane SCHEMBL28967597 0.72 HPGD (0.39) —
SCHEMBL15728413 0.72 HCAR2 (0.42) —
SCHEMBL20150225 0.71 PIM1 (0.32) —
SCHEMBL173616 0.69 VCAM1 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023240205-A1 DEUTERATED COMPOUNDS NEUROCRINE BIOSCIENCES, INC. (US) 2023-12-14 — — WO disclosed
US-20100099689-A1 METHODS OF MODULATING PPAR GAMMA-TYPE RECEPTORS GALDERMA RESEARCH & DEVELOPMENT (FR) 2010-04-22 — — US disclosed
Send feedback